Identification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours

Clinical Endocrinology

Volumn 77, Issue 2, 2012, Pages 195-199

  Rothenbuhler, Anya ^a   Horvath, Anelia ^a   Libé, Rossella ^b,c,d,e   Faucz, Fabio R ^a   Fratticci, Amato ^b,c   Raffin Sanson, Marie L ^b,c,f   Vezzosi, Delphine ^b,c   Azevedo, Monalisa ^a   Levy, Isaak ^a   Almeida, Madson Q ^a   Lodish, Maya ^a   Nesterova, Maria ^a   Bertherat, Jérôme ^b,c,d,e   Stratakis, Constantine A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d université Paris Cité   (France)

^e French COMETE Network for Adrenal Cancer   (France)

^f HÔPITAL AMBROISE PARÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; PHOSPHODIESTERASE; PHOSPHODIESTERASE 8 B; UNCLASSIFIED DRUG;

ADRENAL CORTEX; ADRENAL CORTEX TUMOR; ARTICLE; CANCER PATIENT; CASE CONTROL STUDY; COHORT ANALYSIS; COMPUTER MODEL; CONTROLLED STUDY; EMBRYO; FEMALE; FUNCTIONAL ASSESSMENT; GENE EXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION;

3',5'-CYCLIC-AMP PHOSPHODIESTERASES; ADRENAL CORTEX; ADRENAL GLAND NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84863664769     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04366.x     Document Type: Article

References (16)

1. Horvath, A., Mericq, V., &, Stratakis, C.A., (2008) Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia. New England Journal of Medicine, 358, 750-752.
2. Horvath, A., Giatzakis, C., Tsang, K., et al,. (2008) A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex. European Journal of Human Genetics 16, 1245-1253.
3. Tsai, L.C., Shimizu-Albergine, M., &, Beavo, J.A., (2010) The high affinity cAMP-specific phosphodiesterase 8B (PDE8B) controls steroidogenesis in the mouse adrenal gland. Molecular Pharmacology, 79, 639-648.
4. Horvath, A., Boikos, S., Giatzakis, C., et al,. (2006) A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nature Genetics 38, 794-800.
5. Horvath, A., Giatzakis, C., Robinson-White, A., et al,. (2006) Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population. Cancer Research 66, 11571-11575.
6. Horvath, A., Korde, L., Greene, M.H., et al,. (2009) Functional phosphodiesterase 11A mutations may modify the risk of familial and bilateral testicular germ cell tumors. Cancer Research, 69, 5301-5306.
7. Faucz, F.R., Horvath, A., Rothenbuhler, A., et al,. (2011) Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancer. Journal of Clinical Endocrinology and Metabolism, 96, 135-140.
8. Adzhubei, I.A., Schmidt, S., Peshkin, L., et al,. (2010) A method and server for predicting damaging missense mutations. Nature Methods 7, 248-249.
9. Kumar, P., Henikoff, S., &, Ng, P.C., (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nature Protocols 4, 1073-1081.
10. Dogan, R.I., Getoor, L., Wilbur, W.J., et al,. (2007) SplicePort-an interactive splice-site analysis tool. Nucleic Acids Research 35, 285-291.
11. Libe, R., Fratticci, A., Coste, J., et al,. (2008) Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors. Clinical Cancer Research 14, 4016-4024.
12. Libe, R., Horvath, A., Vezzosi, D., et al,. (2011) Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype. Journal of Clinical Endocrinology and Metabolism, 96, 208-214.
13. Beuschlein, F., Reincke, M., Karl, M., et al,. (1994) Clonal composition of human adrenocortical neoplasms. Cancer Research, 54, 4927-4932.
14. Gicquel, C., Leblond-Francillard, M., Bertagna, X., et al,. (1994) Clonal analysis of human adrenocortical carcinomas and secreting adenomas. Clinical Endocrinology (Oxford), 40, 465-477.
15. Kirschner, L.S., Carney, J.A., Pack, S.D., et al,. (2000) Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nature Genetics, 26, 89-92.
16. Groussin, L., Kirschner, L.S., Vincent-Dejean, C., et al,. (2002) Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. American Journal of Human Genetics, 71, 1433-1442.